complement
system
b
r
c
lectin
pathway
complement
system
pivot
role
defens
infecti
organ
bind
mannanbind
lectin
mbl
ficolin
collectin
carbohydr
acetyl
residu
pathogen
surfac
dimer
mblassoci
serin
proteas
activ
proteolyt
cascad
culmin
format
membran
attack
complex
pathogen
lysi
altern
splice
premrna
encod
result
two
product
regul
activ
cascad
similar
mechan
allow
gene
encod
produc
truncat
protein
polymorph
gene
associ
protein
serum
level
function
activ
sinc
first
report
masp
defici
defici
lectin
pathway
protein
associ
recurr
infect
sever
polymorph
associ
suscept
protect
infecti
diseas
review
summar
find
role
masp
polymorph
serum
level
bacteri
viral
protozoan
infecti
diseas
complement
system
one
major
effector
innat
immun
system
import
bridg
innat
adapt
immun
ricklin
et
al
walport
complement
clear
immun
complex
cell
debri
elicit
immedi
highli
effici
tightli
regul
inflammatori
cytolyt
immun
respons
infecti
organ
includ
bacteria
virus
protozoan
parasit
dunkelberg
song
complement
system
compris
plasma
membraneassoci
protein
kjaer
et
al
complement
activ
lead
proteolyt
cascad
culmin
recruit
inflammatori
cell
phagocytosi
cell
lysi
kjaer
et
al
produc
anaphylatoxin
potent
proinflammatori
mediat
opsonin
cover
pathogen
surfac
mediat
phagocytosi
cascad
culmin
assembl
membran
attack
complex
mac
cell
membran
form
pore
lead
cell
lysi
dunkelberg
song
complement
activ
classic
altern
lectin
pathway
fig
independ
initi
pathway
proteolyt
cascad
converg
toward
activ
major
compon
subsequ
assembl
mac
chen
et
al
activ
classic
pathway
initi
immun
complex
bind
complex
mainli
igm
igg
also
apoptot
cell
pentraxin
pathogen
hand
activ
altern
pathway
occur
spontan
hydrolysi
plasma
lectin
pathway
initi
bind
pattern
recognit
molecul
prm
carbohydr
acetyl
residu
present
surfac
microorgan
known
pamp
pathogenassoci
molecular
pattern
aberr
glycocalyx
pattern
apoptot
necrot
malign
cell
known
damp
damageassoci
molecular
pattern
ricklin
et
al
lectin
pathway
discov
matsushita
fujita
landmark
report
mechan
lectin
pathway
activ
mbl
masp
matsushita
fujita
fact
differ
prm
activ
lectin
pathway
oligom
mannosebind
lectin
mbl
heterom
collectin
alia
collectin
liver
alia
collectin
kidney
oligom
either
also
call
land
hficolin
respect
henriksen
et
al
holmskov
et
al
et
al
recogn
pamp
highli
conserv
structur
present
sever
microorgan
lipoteicho
http
elsevi
ltd
right
reserv
classic
lectin
altern
pathway
complement
activ
classic
pathway
initi
via
bind
complex
consist
molecul
recognit
molecul
target
molecul
surfac
pathogen
subsequ
cleav
bind
coval
pathogen
surfac
cleav
lead
format
complex
convertas
classic
pathway
activ
lectin
pathway
occur
bind
mannosebind
lectin
mbl
oligom
ficolin
oligom
collectin
heterom
complex
mblassoci
serin
proteas
homodim
respect
variou
carbohydr
acetyl
group
surfac
pathogen
pamp
pathogen
associ
molecular
pattern
like
lead
format
convertas
activ
depend
also
cleav
activ
altern
pathway
depend
spontan
lowgrad
hydrolysi
plasma
lead
format
bind
factor
b
homolog
form
complex
cleavag
factor
b
factor
form
altern
pathway
convertas
properdin
stabil
complex
convertas
cleav
bind
coval
next
site
complement
activ
opson
amplifi
cascad
mediat
phagocytosi
well
adapt
immun
respons
addit
addit
molecul
convertas
form
convertas
altern
pathway
classic
lectin
pathway
act
bind
site
initi
assembl
membraneattack
complex
mac
cleavag
wherea
act
potent
anaphylatoxin
form
complex
insert
cell
membran
thereaft
molecul
bind
complex
result
fulli
function
mac
three
pathway
converg
common
termin
pathway
culmin
cell
lysi
death
abba
et
al
acid
gramposit
bacteria
endotoxin
lipopolysaccharid
gramneg
bacteria
fungi
zhu
et
al
glycoprotein
virus
tarr
et
al
protozoa
multicellular
parasit
review
also
bind
damp
alter
carbohydr
pattern
surfac
apoptot
necrot
malign
cell
ren
et
al
dimer
trimer
andor
higher
oligom
trimer
structur
subunit
prm
form
complex
homodim
serin
proteas
known
mblassoci
serin
proteas
masp
initi
form
proenzym
zymogen
kjaer
et
al
bind
prm
target
masp
cleav
activ
dahl
et
al
degn
et
al
et
al
although
autoactiv
long
thought
central
activ
lectin
pathway
ambru
et
al
et
al
matsushita
et
al
differ
author
provid
recent
evid
also
autoactiv
signific
role
activ
et
al
kjaer
et
al
activ
initi
suppos
occur
conform
chang
similar
undergon
complex
classic
pathway
gingra
et
al
recent
proteolyt
cascad
propos
initi
crossactiv
occur
compar
effici
within
cocomplex
compris
homodim
homodim
pentam
higherord
oligom
prm
cluster
juxtaposit
complex
ligand
surfac
prm
may
ident
mbl
fcn
exampl
degn
et
al
although
masp
heterodimer
eg
possibl
vitro
physiolog
import
uncertain
et
al
observ
around
mbl
circul
blood
trimer
trimer
subunit
mbl
associ
tetram
trimer
subunit
mbl
associ
dahl
et
al
impli
major
role
intercomplex
crossactiv
initi
complement
cascad
also
support
imag
kda
complex
obtain
smallangl
xray
scatter
electron
microscopi
kjaer
et
al
nonact
complex
may
form
truncat
protein
also
call
skjoedt
et
al
also
known
smap
stover
et
al
b
takahashi
et
al
lack
serin
proteas
domain
thu
function
activ
associ
mbl
seem
exchang
competit
replac
laursen
et
al
nevertheless
displac
proteolyt
activ
acquir
cleavag
masp
arg
ile
bond
activ
peptid
also
call
linker
peptid
cleavag
gener
two
chain
coval
link
disulfid
bond
heavi
chain
alia
chain
light
chain
alia
b
chain
sato
et
al
heavi
chain
compris
linker
regulatori
domain
ie
ntermin
cub
uegf
bone
morphogenet
domain
amino
acid
residu
follow
epiderm
growth
factor
egf
like
domain
ca
bind
type
approxim
amino
acid
residu
second
cub
domain
two
contigu
complement
control
protein
modul
light
chain
constitut
chymotrypsinlik
serin
proteas
sp
domain
review
kjaer
et
al
domain
respons
ca
depend
dimer
masp
polypeptid
yet
involv
ca
depend
associ
masp
dimer
prm
thielen
et
al
walli
dodd
gene
identifi
earli
bactericid
factor
structur
similar
reactiv
salmonella
typhimurium
takada
et
al
gene
locat
chromosom
takada
et
al
contain
exon
encod
three
protein
premrna
altern
splice
fig
exon
translat
exon
encod
regulatori
domain
first
eight
exon
common
three
protein
mean
share
exon
uniqu
thu
lack
second
ccp
domain
entir
sp
domain
skjoedt
et
al
sp
domain
encod
exon
exon
respect
explain
protein
differ
sp
domain
also
differ
preced
amino
acid
residu
interestingli
sequenc
encod
upstream
sp
domain
intron
activ
serin
residu
encod
agi
codon
reflect
common
origin
uniqu
sp
exon
presum
retrotransposit
sequenc
encod
factor
b
encod
proteas
ascidian
diverg
urochord
subsequ
gene
duplic
event
instead
activ
serin
encod
tcn
codon
typic
chymotrypsin
gene
turn
encod
sequenc
repres
ancestr
serin
proteas
gene
lectin
pathway
appear
earli
cnidaria
kimura
et
al
nonaka
miyazawa
least
gene
singl
nucleotid
polymorph
snp
strongli
link
associ
protein
serum
level
tabl
interestingli
contrast
valu
serum
level
found
associ
snp
locat
near
altern
exon
exclus
exclus
probabl
due
mutual
altern
splice
mechan
exampl
homozygos
snp
intron
gg
associ
increas
decreas
concentr
five
haplotyp
compris
snp
upstream
regulatori
region
seem
also
play
role
common
haplotyp
tag
occur
frequenc
danish
popul
associ
highest
level
lowest
level
et
al
among
non
synonym
variant
describ
gene
locat
domain
occur
around
allel
frequenc
among
european
associ
found
amino
acid
substitut
system
lupu
erythematosu
system
inflammatori
respons
syndrom
sir
andor
sepsi
discov
protein
associ
mbl
matsushita
fujita
protein
contain
amino
acid
residu
amino
acid
leader
peptid
thiel
primarili
express
liver
upregul
acut
phase
respons
knittel
et
al
consid
promiscu
proteas
substrat
bind
groov
wide
resembl
trypsin
rather
earli
complement
proteas
et
al
normal
concentr
serumplasma
around
gml
rang
gml
higher
among
patient
differ
cardioand
cerebrovascular
diseas
level
highest
patient
subacut
myocardi
infarct
median
gml
lowest
acut
ischem
stroke
median
gml
frauenknecht
et
al
addit
express
observ
upregul
primari
uterin
leiomyosarcoma
davidson
et
al
hcv
infectedhepatocyt
cell
line
saeed
et
al
much
higher
propens
autoactiv
ambru
et
al
activ
heterocomplex
larg
oligomer
mbl
produc
respons
convertas
format
et
al
fact
autoactiv
seem
control
initi
lectin
pathway
megyeri
et
al
nevertheless
cleav
therefor
capabl
gener
convertas
alon
ambru
et
al
direct
activ
occur
physiolog
irrelev
ambru
et
al
report
essenti
develop
autoimmuneassoci
inflammatori
tissu
injuri
activ
altern
pathway
complement
experiment
model
inflammatori
arthriti
banda
takahashi
nevertheless
report
role
activ
altern
pathway
confirm
human
shown
play
role
coagul
cleav
factor
xiii
fibrinogen
mediat
format
crosslink
fibrin
although
lower
catalyt
effici
compar
thrombin
krarup
et
al
fact
antithrombin
presenc
heparin
potent
inhibitor
inhibitor
presani
bont
et
al
proteolyt
activ
induc
ca
signal
nfkappab
mapk
pathway
endotheli
cell
proteaseactiv
receptor
megyeri
et
al
activ
lead
releas
activ
chemotaxi
neutrophil
granulocyt
jani
et
al
also
abl
modul
immun
respons
releas
proinflammatori
bradykinin
highmolecular
weight
kininogen
et
al
ubiquit
express
mean
serum
concentr
mgl
rang
mgl
degn
et
al
skjoedt
et
al
evolutionarili
highli
conserv
stover
et
al
occur
serum
mainli
associ
lower
amount
mbl
skjoedt
et
al
far
biolog
role
remain
unclear
cleav
complement
compon
inhibit
zundel
et
al
yongq
et
al
howev
may
reduc
lectin
pathway
activ
due
competit
masp
bind
site
recognit
molecul
recent
propos
role
activ
altern
pathway
mice
iwaki
et
al
howev
human
seem
requir
activ
altern
pathway
togeth
seem
import
role
earli
embryon
develop
shown
effect
five
rare
exon
mutat
four
independ
famili
autosom
recess
syndrom
mingarelli
malpuech
michel
carneval
character
variou
development
disord
implic
mutat
predict
damag
serin
proteas
domain
abolish
enzymat
activ
rooryck
et
al
sirmaci
et
al
may
play
role
defens
acquir
infect
intens
care
unit
icu
diagnos
hospitalacquiredinfect
major
problem
occur
approxim
children
admit
icu
patient
acquir
infect
icu
onadmiss
lower
level
p
result
remain
independ
associ
acquisit
infect
correct
baselin
characterist
risk
factor
lectin
pathway
protein
multivari
logist
regress
analysi
low
level
also
associ
prolong
need
intens
care
irrespect
infect
ingel
et
al
also
call
mblassoci
protein
regul
neg
complement
activ
compet
mbl
ficolin
bind
site
skjoedt
et
al
pavlov
et
al
similarli
larg
express
liver
also
bladder
brain
cervix
colon
prostat
behav
acut
phase
protein
contrast
level
highest
heart
also
decreas
slightli
serum
first
month
birth
degn
et
al
normal
serum
level
around
gml
rang
gml
degn
et
al
associ
cardioprotect
effect
preserv
cardiac
function
decreas
infarct
size
prevent
thrombogenesi
murin
model
ischaemiareperfus
injuri
arteri
thrombosi
inhibit
mbl
deposit
bont
et
al
pavlov
et
al
inhibitori
effect
mbl
deposit
howev
evid
pharmacolog
level
gml
nacetyldglucosamin
bovin
serum
albumin
glcnacbsa
coat
mannanco
plate
interpret
attenu
mechan
mbl
recognit
endogen
ligand
yet
precis
mechan
enabl
inhibit
mbl
deposit
await
elucid
nevertheless
level
relat
cardioand
cerebrovascular
diseas
human
associ
cardiovascular
risk
factor
dyslipidaemia
obes
hypertens
frauenknecht
et
al
base
find
recent
suggest
new
therapeut
approach
consid
treatment
patient
myocardi
ischemiareperfus
injuri
thrombogenesi
well
inflammatori
arthriti
banda
et
al
gene
locat
chromosom
stover
et
al
b
exon
cover
kb
encod
two
protein
fig
exon
translat
exon
encod
signal
peptid
togeth
exon
domain
exon
encod
egflik
domain
exon
encod
second
domain
exon
two
ccp
domain
exon
encod
serin
proteas
domain
utr
region
stover
et
al
truncat
protein
produc
altern
splice
polyadenyl
primari
transcript
gene
exon
exclus
transcript
contain
infram
stop
codon
lead
prematur
termin
translat
process
polyadenyl
signal
result
truncat
protein
kda
stover
et
al
b
takahashi
et
al
variou
polymorph
encompass
region
promot
last
exon
associ
protein
level
serum
tabl
ten
haplotyp
polymorph
associ
low
intermedi
high
produc
haplotyp
boldt
et
al
b
defici
may
occur
homozygot
compound
heterozygot
variant
due
differ
reason
aspgli
substitut
residu
disrupt
calcium
ion
bind
first
domain
individu
snp
turn
unabl
bind
mbl
ficolin
abrog
complement
activ
reduc
concentr
homozygot
european
stengaardpedersen
et
al
thiel
et
al
vall
et
al
yet
rare
duplic
four
aminoacid
within
egf
domain
found
asian
probabl
result
misfold
variant
occur
predict
frequenc
among
african
disrupt
activ
peptid
sp
domain
molecul
still
abl
bind
mbl
probabl
reduc
bind
opportun
fullwork
heterozygot
block
complement
activ
homozygot
besid
three
non
synonym
substitut
associ
modul
level
without
obviou
reason
first
domain
tabl
singl
nucleotid
polymorph
associ
protein
level
function
boldt
et
al
boldt
et
al
thiel
et
al
thiel
et
al
domain
schadt
et
al
thiel
et
al
thiel
et
al
interestingli
polymorph
respons
imbed
within
region
one
strongest
signal
select
sweep
human
genom
ronen
et
al
furthermor
polymorph
intron
associ
opposit
level
probabl
due
interfer
mutual
altern
mrna
splice
boldt
et
al
boldt
et
al
character
thiel
other
late
protein
similar
thiel
et
al
bind
mbl
ficolin
homodim
calciumdepend
manner
epiderm
growth
factor
egf
like
domain
assist
two
surround
cub
domain
feinberg
et
al
although
found
suffici
autoactiv
initi
lectin
pathway
complement
et
al
activ
physiolog
condit
afterward
cleav
complement
compon
thu
gener
convertas
fact
requir
effici
activ
lectin
pathway
thiel
et
al
degn
et
al
et
al
b
kocsi
et
al
megyeri
et
al
compar
serin
proteas
classic
pathway
time
catalyt
activ
rapidli
inhibit
kerr
et
al
also
act
coagul
cascad
cleav
prothrombin
way
factor
xa
gener
crosslink
fibrin
coval
bound
bacteri
surfac
gulla
et
al
predominantli
express
hepatocyt
promot
regul
unterberg
et
al
level
shown
stabl
time
healthi
individu
around
ngml
serumplasma
rang
ngml
ytting
et
al
level
lower
ngml
consid
defici
thiel
level
lower
myocardi
infarct
acut
stroke
patient
compar
patient
stabl
coronari
arteri
diseas
control
frauenknecht
et
al
line
observ
myocardi
ischemia
induc
complement
activ
consumpt
among
critic
ill
children
higher
level
around
ngml
associ
malign
lower
level
around
ngml
associ
cardiac
diseas
ingel
et
al
high
level
also
associ
develop
sever
infect
adult
patient
haematolog
cancer
undergo
chemotherapi
amey
et
al
kda
truncat
protein
produc
altern
splice
gene
present
first
cub
domain
egf
domain
serin
proteas
activ
exon
exclus
infram
stop
codon
polyadenyl
signal
code
four
amino
acid
residu
ctermin
tail
utr
protein
takahashi
et
al
secret
liver
plasma
express
kupffer
cell
similar
median
level
ngml
rang
ngml
nevertheless
minor
fraction
associ
mbl
ficolin
bind
occur
ten
time
lower
affin
compar
degn
et
al
excret
human
urin
may
play
role
inhibit
calcium
oxal
renal
stone
format
degn
et
al
kang
et
al
nucleocapsid
n
protein
sever
acut
respiratori
syndrom
coronaviru
interact
vitro
function
signific
remain
unknown
jl
liu
et
al
b
insuffici
excess
activ
lectin
pathway
may
harm
host
wherea
defici
lectin
pathway
compon
may
clinic
irrelev
healthi
individu
due
redund
immun
system
defici
frequent
associ
increas
suscept
secondari
infect
autoimmun
complic
immunocompromis
patient
granel
et
al
ingel
et
al
et
al
neth
et
al
low
level
exampl
associ
increas
risk
sever
chemotherapyinduc
neutropenia
children
cancer
schlapbach
et
al
acut
decreas
level
earli
phase
septic
shock
correl
inhospit
mortal
charchaflieh
et
al
contrast
increas
level
innat
immun
protein
part
explain
polymorph
correspond
gene
may
contribut
exagger
inflammatori
respons
boldt
et
al
high
postop
level
exampl
associ
poor
prognosi
colorect
cancer
patient
ytting
et
al
genet
integr
gene
encod
lectin
pathway
compon
essenti
complement
activ
regul
snp
gene
reduc
protein
serum
concentr
affect
enzymat
activ
impair
complement
activ
possibl
coagul
develop
proteas
cascad
et
al
rooryck
et
al
thiel
et
al
thiel
et
al
expect
grow
number
infecti
diseas
associ
snp
sinc
first
report
masp
defici
patient
persist
inflammatori
diseas
episod
sever
pneumococc
pneumonia
progress
lung
fibrosi
present
homozygos
domain
stengaardpedersen
et
al
although
variant
includ
list
primari
immunodefici
diseas
geha
et
al
low
clinic
penetr
garcialaorden
et
al
rel
rare
reason
found
associ
common
diseas
investig
date
miller
et
al
olesen
et
al
ramasawmi
et
al
schafranski
et
al
segat
et
al
ytting
et
al
contrast
frequent
variant
actual
found
play
role
suscept
infect
treatment
respons
discuss
mbl
one
identifi
six
decad
ago
abl
inactiv
influenza
viru
ander
et
al
dommett
et
al
actual
recogn
rang
differ
virus
review
although
inhibit
activ
prm
mbl
necessarili
depend
complement
activ
thu
effici
masp
activ
thielen
et
al
masp
well
polymorph
associ
masp
level
function
found
play
role
immun
respons
differ
viral
infect
human
tlymphotrop
viru
retroviru
endem
mani
countri
major
individu
infect
remain
asymptomat
lifelong
wherea
other
develop
sever
diseas
associ
myelopathytrop
spastic
paraparesi
adult
tcell
leukemia
izumo
et
al
studi
involv
patient
northwestern
brazil
associ
suscept
infect
specif
aspart
acid
residu
associ
domin
higher
risk
htlv
infect
heterozyg
homozyg
individu
ci
p
independ
genet
determin
mbl
defici
also
associ
diseas
possess
lowproduc
haplotyp
increas
risk
infect
approxim
associ
viral
load
seen
coelho
et
al
although
level
evalu
studi
known
variant
associ
domin
effect
level
ngml
addit
effect
level
ngml
boldt
et
al
thu
compound
mbl
defici
overproduct
may
play
role
suscept
infect
associ
howev
await
replic
cohort
approxim
million
peopl
worldwid
infect
hepat
c
viru
hcv
barth
et
al
circa
progress
chronic
form
diseas
character
liver
fibrosi
may
progress
cirrhosi
hepatocarcinoma
liver
injuri
hcv
patient
suggest
result
persist
inflammatori
respons
induc
immun
mediat
nonetheless
appropri
activ
innat
immun
system
import
synthesi
antivir
peptid
inhibit
viral
replic
thimm
et
al
regard
mbl
found
bind
hcv
envelop
glycoprotein
activ
complement
hcvinfect
hepatocyt
brown
et
al
liu
et
al
b
mbl
defici
repeatedli
associ
hcv
infect
koutsounaki
et
al
melo
et
al
segat
et
al
wherea
earli
increas
level
correl
better
respons
treatment
hu
et
al
mbl
defici
associ
treatment
respons
alv
pedroso
et
al
eurich
et
al
regard
tulio
et
al
investig
southbrazilian
patient
chronic
hepat
c
found
associ
homozygot
variant
suscept
hcv
ci
p
confirm
find
healthi
popul
boldt
et
al
boldt
et
al
level
higher
patient
without
variant
genotyp
caus
partial
mbl
defici
yayo
also
posit
associ
hcv
infect
patient
group
alv
pedroso
et
al
thu
similarli
infect
mbl
defici
variant
may
exert
synergist
effect
increas
suscept
hcv
infect
replic
within
cohort
need
confirm
result
nevertheless
associ
polymorph
level
treatment
respons
liver
fibrosi
suggest
immunomodulatori
role
fibrosi
progress
treatment
ifn
ribavirin
tulio
et
al
contrast
mbl
defici
neg
associ
sever
liver
fibrosi
alv
pedroso
et
al
lower
level
function
mbl
protein
would
expect
impair
report
thrombinlik
activ
complex
ambru
et
al
presani
et
al
reduc
fibrin
crosslink
gener
fibrot
liver
tissu
fact
base
premis
mbl
mainli
produc
liver
reactiv
profil
similar
thrombin
studi
carri
investig
mbl
complex
develop
hcvrelat
liver
fibrosi
english
patient
corrobor
previou
find
mbl
defici
exert
protect
effect
liver
fibrosi
median
mbl
serum
level
higher
patient
sever
liver
fibrosi
mild
diseas
p
enzymat
activ
complex
correl
mbl
level
spearman
rho
p
also
found
rais
hcv
patient
sever
fibrosi
unitsmin
compar
mild
fibrosi
unitsmin
nonhcv
mild
fibrosi
unitsmin
control
unitsmin
moreov
complex
activ
remain
associ
adjust
mbl
concentr
multivari
model
per
unit
ci
p
brown
et
al
similar
result
obtain
other
egyptian
cohort
present
strong
associ
hcvinduc
liver
fibrosi
activ
complex
adjust
mbl
level
p
el
saadani
et
al
furthermor
gene
upregul
present
higher
mrna
express
hepatocyt
cell
line
infect
genotyp
hcv
clone
reveal
two
differ
group
use
microarray
realtim
rtpcr
analysi
blackham
et
al
saeed
et
al
activ
recombin
actual
shown
directli
caus
hepat
stellat
cell
hsc
differenti
myofibroblast
phenotyp
vitro
measur
morpholog
express
alpha
smooth
muscl
actin
tissu
inhibitor
saeed
et
al
cell
differenti
culmin
deposit
excess
fibrogen
extracellular
matrix
protein
may
occur
bind
protein
proteaseactiv
receptor
par
famili
suggest
human
vascular
endotheli
cell
megyeri
et
al
human
endogen
retrovirus
herv
herp
virus
consist
associ
multipl
sclerosi
ms
inflammatori
diseas
character
damag
nerv
cell
brain
spinal
cord
even
though
activ
herv
rare
found
healthi
individu
ms
patient
elev
level
antiherv
gag
env
antibodi
serum
cerebrospin
fluid
direct
toward
distinct
herv
epitop
studi
case
sporad
ms
ms
patient
famili
ms
includ
unaffect
rel
author
found
signific
neg
correl
level
seroreact
herv
peptid
patient
activ
diseas
spearman
r
p
low
level
also
correl
high
level
ms
patient
activ
diseas
borderlin
signific
spearman
r
p
interestingli
higher
level
common
mbldefici
individu
regardless
affect
p
studi
higher
express
seem
occur
compens
mechan
mbl
defici
higher
level
may
play
protect
role
establish
diseas
composit
specif
structur
featur
bacteri
pamp
may
favour
prevent
bind
prm
lectin
pathway
complement
initi
shown
earli
eighti
kawakami
et
al
call
rarf
complex
later
identifi
mbl
interact
salmonella
enterica
serovar
typhimurium
kawakami
et
al
author
suggest
crucial
role
lipopolysaccharid
lp
mbl
bind
featur
later
found
inhibit
lipooligosaccharid
sialyat
devyatyarovajohnson
et
al
jack
et
al
capsul
krarup
et
al
besid
recogn
bind
differ
bacteri
pamp
review
therebi
initi
complement
cascad
prm
lectin
pathway
report
opson
bacteria
kuhlman
et
al
elicit
cytokin
releas
phagocyt
jack
et
al
nevertheless
prmmediat
phagocytosi
may
potenti
inhibit
duu
et
al
thu
rel
concentr
function
integr
masp
may
balanc
lectin
pathwaymedi
antibacteri
respons
complement
activationform
membraneattack
complex
opsonizationphagocytosi
leprosi
also
known
hansen
diseas
caus
mycobacterium
lepra
invad
macrophag
schwann
cell
host
although
small
group
infect
individu
develop
diseas
differ
immunolog
respons
lead
wide
spectrum
clinic
manifest
progress
irrevers
disabl
molecular
mechan
involv
infect
immun
evas
bacillu
still
well
understood
due
challeng
cultiv
lepra
vitro
vivo
tabouret
et
al
lepra
take
advantag
opson
enter
phagocyt
order
establish
intracellular
infect
schlesingert
horwitz
reason
low
level
lectin
pathway
prm
long
propos
benefici
infect
disfavor
bacteri
dissemin
host
tissu
gar
et
al
fact
evid
protect
effect
low
mbl
level
well
correspond
haplotypesgenotyp
gene
infect
develop
lepromat
leprosi
sever
form
diseas
character
strong
respons
boldt
et
al
de
messiasreason
et
al
dornel
et
al
gar
et
al
sapkota
et
al
first
studi
possibl
associ
leprosi
level
gener
polymorph
leprosi
patient
lower
serum
level
compar
control
higher
frequenc
low
produc
allel
polymorph
associ
defici
domin
effect
leprosi
suscept
p
yet
genotyp
compos
intermedi
produc
haplotyp
protect
diseas
p
also
associ
lepromat
form
diseas
low
produc
polymorph
thu
contrast
prm
low
level
increas
suscept
leprosi
per
se
lepromat
leprosi
form
boldt
et
al
replic
studi
popul
need
order
confirm
genet
associ
tuberculosi
caus
mycobacterium
tuberculosi
affect
mostli
lung
pulmonari
tb
also
affect
organ
extrapulmonari
tb
one
third
world
popul
infect
bacterium
although
small
proport
infect
peopl
develop
diseas
curabl
million
million
peopl
acquir
diseas
everi
year
access
treatment
without
treatment
mortal
rate
high
around
patient
die
year
place
tuberculosi
second
caus
death
due
singl
infecti
organ
first
aid
world
health
organ
mbl
abl
recogn
differ
mycobacteri
cell
wall
compon
contain
mannos
mannosyllipoarabinomannan
manlam
arabinosyllam
lipomannan
phosphatidylinositol
mannosid
polotski
et
al
nevertheless
mycobacteria
caus
tuberculosi
bind
mbl
equal
well
eg
mycobacterium
africanum
bind
recombin
human
mbl
effici
tuberculosi
furthermor
ghanaian
cohort
mbl
defici
associ
protect
africanumtuberculosi
thye
et
al
mbl
defici
nevertheless
shown
increas
suscept
infect
northwestern
brazil
da
cruz
et
al
addit
found
recogn
manlam
protect
virul
tuberculosi
strain
vitro
vivo
defici
caus
homozygos
amino
acid
substitut
also
recent
report
two
person
pulmonari
tuberculosi
sokolowska
et
al
snp
possibl
regulatori
role
gene
express
associ
suscept
diseas
eg
heterozyg
tc
genotyp
snp
locat
intron
increas
suscept
tuberculosi
chines
individu
ci
p
especi
cook
solid
fuel
investig
snp
associ
effect
snpshaplotyp
polymorph
yet
investig
geneenviron
interact
investig
chen
et
al
may
explain
contrast
result
tb
associ
studi
compon
lectin
pathway
thu
need
replic
differ
cohort
bacteria
pseudomona
aeruginosa
caus
variou
opportunist
infect
wound
pulmonari
urinari
tract
blood
stream
infect
especi
immunocompromis
individu
cystic
fibrosi
patient
chatzinikola
et
al
santucci
et
al
import
characterist
pathogen
resist
mani
antibacteri
agent
capac
surviv
differ
environ
express
virul
factor
trautmann
et
al
defici
mice
model
show
signific
associ
surviv
express
cytokin
mice
infect
p
aeruginosa
author
conclud
lectin
pathway
essenti
complement
activ
p
aeroginosa
infect
kenawi
et
al
previou
studi
cystic
fibrosi
patient
mutat
gene
associ
deterior
lung
function
higher
frequenc
p
aeruginosa
bacteri
colon
gabold
et
al
gar
et
al
haerynck
et
al
contrast
associ
bacteri
infect
level
andor
polymorph
found
two
independ
studi
carlsson
et
al
haerynck
et
al
despit
report
extrem
sever
lung
diseas
cystic
fibrosi
patient
homozyg
variant
olesen
et
al
one
studi
author
nevertheless
observ
mbl
activ
decreas
significantli
defici
cystic
fibrosi
patient
surprisingli
healthi
control
carlsson
et
al
contrast
synonym
snp
exon
encod
serin
proteas
domain
found
associ
p
aeruginosa
colon
human
cystic
fibrosi
patient
heterozyg
homozyg
less
frequent
allel
polymorph
earlier
colon
p
aeruginosa
homozyg
wild
type
patient
vs
year
age
respect
p
associ
may
fact
due
hitchhik
effect
anoth
variant
sinc
author
investig
three
snp
gene
haerynck
et
al
rheumat
fever
rf
sever
sequel
chronic
rheumat
heart
diseas
rhd
chronic
inflamm
occur
genet
predispos
children
teenag
result
oropharynx
infect
streptococcu
group
affect
heart
joint
nervou
system
skin
may
progress
rheumat
heart
diseas
stenosi
valv
tissu
perman
heart
damag
chang
mbl
promot
complement
deposit
streptococc
cell
wall
bind
glcnac
neth
et
al
lipoteicho
acid
lynch
et
al
respect
nevertheless
mbl
level
significantli
higher
patient
rhd
control
probabl
caus
undesir
complement
activ
tissu
damag
rhd
patient
wherea
variant
lead
low
mbl
level
found
protect
rf
schafranski
et
al
instead
level
found
lower
patient
histori
rf
south
brazil
rhd
without
cardiac
lesion
rfo
control
furthermor
low
produc
variant
neg
associ
rf
p
rhd
p
haplotyp
produc
higher
concentr
share
intron
polymorph
increas
suscept
rhd
p
thu
gene
polymorph
protein
level
seem
play
import
role
develop
rf
establish
rhd
catarino
et
al
poststreptococc
acut
glomerulonephr
psagn
also
result
previou
infect
skin
throat
caus
nephritogen
strain
group
betahemolyt
streptococci
antibodi
produc
fight
infect
may
eventu
settl
glomeruli
caus
inflamm
hisano
et
al
studi
kidney
tissu
obtain
percutan
renal
biopsi
patient
psagn
author
found
glomerular
coloc
mbl
glomerular
deposit
fibrinogen
detect
immunohistochem
character
five
seven
patient
deposit
two
eleven
patient
without
complex
deposit
moreov
three
seven
patient
deposit
hematuria
prolong
wherea
patient
without
deposit
urinalysi
normal
p
hisano
et
al
streptococcu
pneumonia
common
caus
bacteria
respiratori
infect
earli
infanc
old
age
krone
et
al
pneumococc
otiti
media
common
among
children
pneumococc
pneumonia
frequent
caus
morbid
mortal
among
elderli
peopl
also
individu
underli
special
condit
chronic
diseas
receiv
immunosuppress
therapi
hiv
posit
asplen
patient
risk
seriou
pneumococc
infect
consid
complement
activ
protect
microorgan
invas
mechan
either
depend
independ
antibodi
differ
studi
investig
role
complement
pathway
use
complement
defici
mice
elimin
igg
igm
opson
pneumococci
guinea
pig
model
pneumococc
bacteraemia
found
earli
eighti
complet
reli
complement
activ
brown
et
al
although
classic
pathway
initi
propos
mainli
respons
pneumonia
opson
brown
et
al
neither
classic
altern
activ
pathway
compens
absenc
lectin
pathway
defici
mice
highli
suscept
pneumococc
infect
fail
opson
pneumonia
fact
mice
present
similar
infect
surviv
time
mortal
rate
previous
found
defici
mice
employ
strain
bacteria
mice
dose
rout
infect
studi
also
demonstr
mous
ficolina
mbla
c
critic
pattern
recognit
molecul
activ
complement
via
lectin
pathway
surfac
pneumonia
brown
et
al
author
also
demonstr
mous
ficolina
close
relat
human
mbla
c
critic
pattern
recognit
molecul
activ
complement
via
lectin
pathway
surfac
pneumonia
anoth
group
concomitantli
prove
essenti
surviv
ficolindefici
mice
infect
streptococcu
pneumonia
take
account
result
defici
mice
surpris
first
patient
describ
homozyg
mutat
present
recurr
infect
includ
sever
pneumococc
pneumonia
stengaardpedersen
et
al
nevertheless
investig
conduct
human
pneumococc
bacteremia
besid
casecontrol
studi
hiv
posit
patient
particular
studi
author
find
associ
three
polymorph
associ
level
horcajada
et
al
light
report
associ
mbl
respiratori
infect
includ
metaanalysi
show
associ
mbl
defici
death
patient
pneumococc
infect
review
eisen
investig
masp
level
polymorph
suscept
pneumococc
diseas
warrant
take
account
capac
prm
lectin
pathway
recogn
bind
differ
protozoan
parasit
ambrosio
de
messiasreason
kahn
et
al
klabund
et
al
korir
et
al
modul
cytokin
chemokin
level
infect
boldt
et
al
associ
dysfunct
masp
molecul
well
masp
level
expect
malaria
infect
diseas
caus
parasit
plasmodium
falciparum
endem
area
subsaharan
africa
one
two
million
affect
children
year
age
die
year
gupta
et
al
variou
genet
variant
modul
immun
respons
malariaaffect
popul
probabl
maintain
among
balanc
select
regard
lectin
pathway
compon
mbl
seem
play
import
role
malaria
infect
control
parasitemia
low
protein
level
also
low
mbl
produc
polymorph
associ
malaria
associ
sever
anemia
gabones
children
boldt
et
al
luti
et
al
posit
parasit
count
asymptomat
p
falciparum
infect
gabones
adult
boldt
et
al
ghanaian
children
holmberga
et
al
well
placent
malaria
primipar
ghanaian
women
holmberg
et
al
despit
rel
import
lectin
pathway
fight
p
falciparum
infect
polymorph
investig
placent
malaria
among
sever
variant
genotyp
primipar
ghanaian
women
placent
malaria
none
investig
variant
associ
diseas
nevertheless
variant
encod
exon
show
protect
effect
ci
p
especi
presenc
hemozoin
malari
pigment
placenta
featur
suggest
chronic
placent
infect
ci
p
also
trend
protect
effect
low
birth
weight
ci
p
furthermor
allel
encod
major
variant
occur
absolut
linkag
disequilibrium
allel
encod
major
variant
found
opposit
effect
increas
suscept
diseas
p
mutat
actual
disrupt
activ
peptid
still
abl
bind
prm
lectin
pathway
activ
complement
reason
dysfunct
protein
protect
placent
malaria
nevertheless
well
understood
especi
take
account
mbl
defici
present
opposit
effect
increas
suscept
placent
malaria
patient
group
holmberg
et
al
thu
associ
sole
due
balanceddisturb
complement
activ
process
depend
intact
mbl
molecul
phagocytosi
expect
hamper
sinc
variant
abl
bind
prm
lectin
pathway
thu
block
interact
site
phagocyt
receptor
duu
et
al
addit
gener
opson
fragment
complement
activ
would
mean
less
hemozoin
uptak
explain
et
al
epimastigot
flagel
form
triatomina
vector
suscept
complementmedi
lysi
natur
condit
howev
never
confront
hand
amastigot
trypomastigot
form
infect
human
resist
complementmedi
lysi
moreov
use
recognit
mblficolinsmasp
complex
invad
host
cell
sever
complement
inhibitor
molecul
express
cruzi
surfac
gp
fischer
et
al
trypanosoma
cruzidecay
acceler
factor
norri
et
al
complement
regul
protein
norri
complement
receptor
inhibitor
trispan
inal
et
al
trypanosoma
cruzi
calreticulin
ferreira
et
al
mostli
glycoprotein
act
destabil
complex
form
protein
complement
system
strong
neg
associ
hemozoin
placent
level
less
consequ
hemozoindriven
inflamm
tissu
damag
kalantari
et
al
explain
neg
associ
chronic
placent
malaria
function
studi
variant
possibl
clarifi
issu
chaga
diseas
one
import
neglect
tropic
diseas
worldwid
affect
million
peopl
latin
america
incid
new
case
per
year
causal
parasit
trypanosoma
cruzi
flagel
protozoan
transmit
human
sting
bloodsuck
triatomin
bug
lescur
et
al
infect
lectin
pathway
becom
effici
activ
bind
mbl
nand
oglycosyl
molecul
parasit
metacycl
trypomastigot
amastigot
surfac
fig
kahn
et
al
lysi
cruzi
depend
cleav
nonimmun
serum
deplet
mbl
ficolin
classic
pathway
ineffici
activ
complement
respons
altern
pathway
slowli
activ
presenc
parasit
therefor
lectin
pathway
seem
play
import
role
control
cruzi
infect
human
cestari
ramirez
cestari
et
al
issu
nevertheless
controversi
cruziinfect
murin
model
gibson
et
al
ribeiro
et
al
suscept
cruzi
infect
increas
mice
even
though
mice
lack
function
activ
lectin
pathway
ribeiro
et
al
cruzi
becom
infect
abl
evad
complement
activ
therebi
invad
host
cell
sever
pathogen
present
molecul
stop
complement
cascad
inhibit
convertas
format
cestari
et
al
one
molecul
express
cruzi
trypomastigot
infecti
state
complement
receptor
inhibitor
trispan
crit
deriv
peptid
molecul
inhibit
bind
parasit
kill
biochem
studi
shown
crit
extracellular
domain
inhibit
cleavag
convertas
format
cestari
et
al
chagas
patient
present
indetermin
symptomat
cardiac
digest
cardiodigest
form
diseas
persist
parasit
could
result
desialy
myocardi
endotheli
cell
subsequ
complementdriven
tissu
injuri
onset
symptom
aiello
et
al
higher
levelsfunct
effici
lectin
pathway
compon
would
thu
expect
increas
harm
effect
posit
associ
symptomat
diseas
fact
observ
mbl
variant
luz
et
al
luz
et
al
opposit
nevertheless
observ
regard
polymorph
chronic
chagas
patient
symptomat
actual
higher
frequenc
low
produc
genotyp
homozygot
heterozygot
exclud
intron
allel
control
p
compar
chronic
symptomat
indetermin
chaga
patient
higher
frequenc
cd
haplotyp
c
observ
among
first
group
ci
p
genotyp
cd
without
promot
ci
p
cardiac
symptomat
patient
even
stronger
associ
genotyp
ci
p
high
prm
level
low
level
postul
author
lead
increas
mbldriven
phagocytosi
higher
inflammatori
activ
injuri
chronic
chaga
diseas
summar
strong
evid
complement
activ
cruzi
depend
associ
mbl
ficolin
cleav
effici
lysi
parasit
polymorph
might
use
prognost
biomark
chaga
diseas
allow
fast
identif
patient
higher
risk
develop
chronic
symptomat
form
boldt
et
al
b
possibl
howev
condit
replic
result
genet
associ
complement
system
import
function
fight
infect
ultim
act
pathogen
lysi
infect
clearanc
activ
masp
lectin
pathway
complement
essenti
step
establish
immun
respons
pathogen
infect
masp
serum
level
sometim
driven
known
genet
variant
relat
number
viral
bacteri
protozoan
infect
variant
associ
differ
individu
suscept
diseas
well
diseas
outcom
complic
howev
sinc
unlik
prior
diseas
protein
measur
usual
difficult
differenti
serum
level
implic
caus
diseas
result
diseas
develop
treatment
respons
associ
polymorph
gener
low
genet
express
well
non
function
masp
protein
lead
compromis
immun
respons
pathogen
facilit
infect
diseas
progress
howev
complement
system
present
dual
role
diseas
suscept
might
harm
excess
activ
promot
tissu
damag
lack
activ
predispos
infect
suscept
observ
dual
behavior
reinforc
import
fine
balanc
complement
regul
also
particip
coagul
system
activ
endotheli
cell
induc
proinflammatori
respons
gulla
et
al
et
al
increas
difficulti
understand
role
infecti
diseas
review
sever
pioneer
studi
select
discuss
order
pinpoint
import
masp
protein
gene
polymorph
suscept
infect
clinic
progress
chronic
infecti
diseas
result
underlin
expect
import
masp
activ
lectin
pathway
also
gener
fibrin
clot
within
context
coagul
cascad
base
propos
function
immunomodul
function
equal
anticip
much
work
remain
done
especi
regard
polymorph
function
studi
role
play
truncat
protein
well
replic
uniqu
diseas
associ
studi
done
diseas
previous
associ
polymorph
level
mbl
ficolin
investig
well
first
foremost
masp
protein
level
genet
polymorph
modul
masp
level
function
may
evalu
immunocompromis
atrisk
patient
improv
diseas
outcom
use
earli
therapeut
prevent
measur
